May 29, 2015
Stem cells collected during the process of umbilical cord blood banking after a mother’s stages of pregnancy are currently being used to treat more than 80 diseases, including many types of cancer and anemia treatment. With stem cell research continually expanding, new treatments are being discovered on a regular basis, which is why you should consider cord blood banking during your pregnancy stages if you are an expecting mother.
One of the ways that malignant cancer can be effectively treated is through adoptive immunotherapy that utilizes cytokine-induced killer (CIK) cells. Other types of CIK cells are those which are derived from umbilical cord blood. These cord blood cells (CB-CIK cells) have been studied both in vitro and in vivo, as studies assess the safety of administering CB-CIK cells to cancer patients.
In one study*, 15 patients with malignant cancer received CB-CIK cells, which means they benefited from the decision a mother-to-be made during her stages of pregnancy to collect and store her child’s umbilical cord blood, which was most likely donated to a public cord blood bank. (a service which CariCord offers.) The study concluded with many of the patients showing signs of great improvement, including full and partial remissions.
The results of this study are great news for the umbilical cord blood banking field, as well as cancer patients. Stem cell research now shows that it is safe to treat malignant cancer with CB-CIK cells, which were produced from cord blood an expecting mother made the decision to bank during her pregnancy stages. This is especially good news for cancer patients in poor health, as well as older patients who cannot withstand repeated blood collections, as an alternative treatment method utilizing cord blood is available and has shown to be a safe and effective way to treat cancer. Cord blood can also be used for anemia treatment as well, which is why expecting mothers should consider storing it through CariCord during their stages of pregnancy.
*CytoTherapy - Efficacy and safety of cord blood–derived cytokine-induced killer cells in treatment of patients with malignancies, Published Online: May 09, 2015
May 27, 2015
Umbilical cord blood banking is a fast-growing field of modern stem cell research. Because cord blood can be used to treat more than 80 diseases, including cancers, leukemia, blood disorders, and anemia treatment, a mother’s decision to save her child’s cord blood during her stages of pregnancy can play a critical role in the life of the child at a later point. This is why CariCord’s private family cord blood bank exists, and why we encourage mothers to consider utilizing this invaluable service, no matter which of their pregnancy stages they are currently in.
Many patients with inherited or acquired blood diseases, including sickle cell anemia, can only be cured by receiving a transplant of normal blood stem cells, appropriate cells, which could be collected during the cord blood banking process. This is why we are very happy that the New York State Stem Cell Science Program has awarded a $15.7 million, four-year research grant to a consortium of scientists and transplant clinicians at the Ansary Stem Cell Institute at Weill Cornell Medical College and the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center.
For patients with sickle cell anemia in need of treatment, as well as other types of blood disorders, this is good news! Umbilical cord blood banking can presently treat many types of blood disorders, and we hope that the research that results from this grant will be able to find more cures and develop more treatments. There may be new treatments utilizing cord blood available tomorrow as stem cell research advances, which is why expecting mothers in various stages of pregnancy should consider umbilical cord blood banking today.
When you choose private umbilical cord banking through CariCord, you can rest assured that your newborn’s cells will be collected and stored in a secure facility after your pregnancy stages. In the event that they are ever needed for a blood or anemia treatment, they will be available at your disposal. A simple decision during your stages of pregnancy to choose CariCord could play a crucial role in your child’s life in the future.
May 25, 2015
When skin wounds occur, the healing process can be quite lengthy and take a period of time, just as stages of pregnancy take time. The dynamic healing process involves inflammation, re-epithelization, granulation, vascularization, and tissue remodeling. The use of stem cell therapy has been utilized to help heal skin wounds that seem to be otherwise delayed in their healing process. Commonly used methods for manipulating stem cell behaviors to help heal skin wounds include the administration of genetic modifications and biochemical cocktails, but these methods are often considered impractical for clinical use, due to their potential side effects. In order to utilize cord blood stem cell therapy in the process of healing skin wounds, it is important to be able to regulate the cell behaviors with predictable methods. The development of a safe and practical way to regulate stem cell migration is key in the skin wound-healing field area of stem cell research.
Arachidonic acid is often released during skin injuries, and scientists engaged in the process of stem cell research have not yet fully studied how arachidonic acid modulates wound repair, if treated with stem cells collected during the process of umbilical cord blood banking. This is why it is important for expecting mothers to consider cord blood banking during their pregnancy stages, because stem cell research is constantly finding new uses for cord blood. A recent study took human umbilical cord blood mesenchymal stem cells and stimulated them with arachidonic acid. This study found that these stem cells, pre-treated with arachidonic acid, enhanced wound filling, re-epithelization, and angiogenesis in a skin wound model utilized on a lab mouse.
In addition to potential skin wound healing, mesenchymal stem cells collected after a mother’s pregnancy stages during the umbilical cord blood banking process can be used for anemia treatment. Cord blood can also be used to treat various types of cancers and leukemias. In all, cord blood can be used to treat more than 80 diseases, with stem cell research continually finding and developing new treatments and therapies that can utilize cord blood. This is why a mother’s choice to bank her newborn’s cord blood, made during her stages of pregnancy, can potentially have a life-altering impact in the future.
May 22, 2015
CariCord is proud to announce a collaboration with the International Space Medicine Consortium (ISMC), E-P Therapeutics, and Forever Identity to provide cord blood units to the ISMC for studies and testing of umbilical cord blood stem cell survivability under Micro Gravity simulation. The Micro Gravity testing will simulate the conditions onboard the International Space Station and activities in Low Earth Orbit. The study will investigate diagnostic and therapeutic protocols addressing traumatic brain injury and intracranial pressure in the space mission environment.
The results will be critical to the ISMC, as they work to improve space medicine and its unmet medical challenges. ISMC is committed to connecting people and space exploration by pioneering space medicine technologies and applications, and they are benefitting from cord blood stem cell research. ISMC is positioned to support future United States and international human spaceflight missions and the emerging commercial space tourism industry.
The team at CariCord is honored to have been chosen by the ISMC as the supplier of cord blood units that were donated by mothers after their stages of pregnancy for this study. In a press release, ISMC an spokesperson named CariCord and our partner, ClinImmune Labs, as “one of the largest and highest quality stem cell repositories in the world.” They also noted that our inventory of FDA-licensed cord blood drug units at our secure University of Colorado Medical Center repository had some of the highest TNC levels. This means we are an excellent choice to consider for umbilical cord blood banking during your pregnancy stages, especially since cord blood can be used for anemia treatment.
This study has begun as of May 2015, under the direction of Dr. Steven Diamond and Dr. Thais Russomano at the ISMC in Washington DC. Dr. Diamond and Dr. Russomano serve as the President / COO and Senior Vice President / Chief Medical Officer of ISMC, respectively.
In the future, CariCord will also be conducting research to discover new uses of newborn cord blood stem cells in conjuction with ISMC and other strategic partners. We are expanding stem cell research to find new potential treatments and cures for diseases utilizing units that were collected through umbilical cord blood banking. Currently, cord blood that is collected at the birth of a child after a mother’s stages of pregnancy is known to treat more than 80 diseases, including anemia treatment.